Literature DB >> 35821469

A Simple, Robust, and Affordable Bioluminescent Assay for Drug Screening Against Infective African Trypanosomes.

Estefania Dibello1,2, Marcelo A Comini3, Diego Benítez4.   

Abstract

This chapter introduces a simple and robust in vitro viability assay to screen bioactive small molecules (e.g., natural, synthetic) against the monomorphic and infective (bloodstream) form of Trypanosoma brucei brucei. The assay relies on a bioluminescent transgenic parasite harboring a genetically encoded copy of a thermostable redshifted firefly luciferase from Photinus pyralis.The major advantages of the assay are simplicity and cost efficiency, along with excellent quality parameters. The bioassay allows estimating parasite numbers and viability (and metabolic state) as a function of bioluminescence (BL) signal. Parasites are grown in the presence of the molecules of interest in a 96-well microplate, and 24 h later, BL is determined with a simple protocol lacking washing steps, using cost-efficient reagents with a reasonable readout time for high-throughput applications.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bioluminescence; D-Luciferin; Drug discovery; Redshifted firefly luciferase; Trypanosoma brucei

Mesh:

Substances:

Year:  2022        PMID: 35821469     DOI: 10.1007/978-1-0716-2453-1_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

1.  Development of resazurin-based assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei rhodesiense strain STIB 900 for the identification of potential anti-trypanosomal agents.

Authors:  Kah Tee Lim; Zuriati Zahari; Azimah Amanah; Zafarina Zainuddin; Mohd Ilham Adenan
Journal:  Exp Parasitol       Date:  2016-01-07       Impact factor: 2.011

2.  Development of an Alamar Blue viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427.

Authors:  Melissa L Sykes; Vicky M Avery
Journal:  Am J Trop Med Hyg       Date:  2009-10       Impact factor: 2.345

3.  Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.

Authors:  Joana Faria; Carolina B Moraes; Rita Song; Bruno S Pascoalino; Nakyung Lee; Jair L Siqueira-Neto; Deu John M Cruz; Tanya Parkinson; Jean-Robert Ioset; Anabela Cordeiro-da-Silva; Lucio H Freitas-Junior
Journal:  J Biomol Screen       Date:  2014-10-23

4.  Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei.

Authors:  Zachary B Mackey; Arthur M Baca; Jeremy P Mallari; Beth Apsel; Anang Shelat; Elizabeth J Hansell; Peter K Chiang; Brian Wolff; Kiplin R Guy; Janice Williams; James H McKerrow
Journal:  Chem Biol Drug Des       Date:  2006-05       Impact factor: 2.817

5.  The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro.

Authors:  B Räz; M Iten; Y Grether-Bühler; R Kaminsky; R Brun
Journal:  Acta Trop       Date:  1997-11       Impact factor: 3.112

6.  Propidium iodide-based methods for monitoring drug action in the kinetoplastidae: comparison with the Alamar Blue assay.

Authors:  Matthew K Gould; Xuan Lan Vu; Thomas Seebeck; Harry P de Koning
Journal:  Anal Biochem       Date:  2008-08-03       Impact factor: 3.365

7.  Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis.

Authors:  Tana Bowling; Luke Mercer; Robert Don; Robert Jacobs; Bakela Nare
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-03-03       Impact factor: 4.077

8.  Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign.

Authors:  Melissa L Sykes; Jonathan B Baell; Marcel Kaiser; Eric Chatelain; Sarah R Moawad; Danny Ganame; Jean-Robert Ioset; Vicky M Avery
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29

9.  Highly sensitive in vivo imaging of Trypanosoma brucei expressing "red-shifted" luciferase.

Authors:  Alex P McLatchie; Hollie Burrell-Saward; Elmarie Myburgh; Michael D Lewis; Theresa H Ward; Jeremy C Mottram; Simon L Croft; John M Kelly; Martin C Taylor
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21

10.  Establishment of ATP-based luciferase viability assay in 96-well plate for Trypanosoma congolense.

Authors:  Keisuke Suganuma; Puttik Allamanda; Hassan Hakimi; Mo Zhou; Jose Ma Angeles; Shin-ichiro Kawazu; Noboru Inoue
Journal:  J Vet Med Sci       Date:  2014-07-23       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.